Skip to main content
Current Neuropharmacology logoLink to Current Neuropharmacology
. 2025 May 6;23(13):1744–1752. doi: 10.2174/011570159X341759250119141806

Vitamin C Protects from Impairment of Memory Induced by E-Cigarette Aerosol Exposure

Karem H Alzoubi 1,2,*, Omar F Khabour 3, Nour Al-Sawalha 2, Enaam M Al Momany 4, Anan Jarab 5,6,7, Razan Haddad 8, Nasr Alrabadi 9, Mohammad AY Alqudah 1,2, Toka K Al-zoubi 1, Thomas Eissenberg 10,11
PMCID: PMC12645129  PMID: 39936419

Abstract

Introduction

E-cigarettes (EC) have been shown to impair memory by disrupting the balance involving ROS and antioxidant enzymes, leading to oxidative stress. Vitamin C (VitC) is a strong antioxidant with cell protective efficacy and scavenges free radicals. The present study evaluated VitC for potential protective effects against EC-induced memory impairment in rat models.

Methods

The animals were exposed to EC for 2 hr/day, with a one-hour break in between, for five days per week over four weeks. Simultaneously, animals were administered Vitamin C at 100 mg/ kilogram/bw/day via oral gavage five days/week/for four weeks. After the treatment and exposure period concluded, spatial learning and memory were evaluated using the Radial Arms Water Maze. Furthermore, the oxidative stress biomarkers levels (GSSG, GSH, GSH/GSSG, TBARS, Catalase, and GPx) and brain-derived neurotrophic factor (BDNF) were measured in the hippocampus tissues.

Results

The findings indicated that EC had a detrimental effect on the short-term and long-term memory of the animals (p < 0.05). Additionally, EC decreased the levels of GPx, SOD, GSH, the GSH/GSSG ratio, and BDNF (p < 0.05). Furthermore, the GSSG level was significantly elevated (p < 0.05) by EC. However, Vitamin C prevented impairment of memory and restored levels of biomarkers of oxidative stress and BDNF.

Conclusion

To summarize, exposure to EC resulted in impairments of memory, both short-term and long-term. However, the administration of Vitamin C prevented these negative effects by its antioxidant properties.

Keywords: Vitamin C, E-cigarette, memory impairment, aerosol, oxidative stress, tobacco

1. INTRODUCTION

Tobacco use is widely recognized as a significant threat to global health [1, 2]. In 2016, waterpipe and electronic cigarettes (e-cigarettes or ECs) were classified as tobacco products by the FDA, mandating their regulation to be similar to tobacco cigarettes [2]. They were first introduced to the world market in the mid to late 2000s and were marketed as a less harmful or ‘safer’ substitution to conventional smoking of tobacco [1-4]. Globally, data is limited on the number of individuals using ECs [1]. Jerzyński et al. utilized established epidemiological calculations to estimate that the global usage of electronic cigarettes (ECs) among adults reached approximately 68 million in 2020 [5]. EC use is an emerging trend among young people due to several reasons, which include the misperception of being a harm reduction approach for smokers, the availability of many pleasant flavors, the absence of regulations following their introduction to the wider market, and its use as a potential smoking cessation tool [2-4, 6].

The main components of ECs include a cartridge, tank, or pod filled with fluid (often contains nicotine, humectants such as vegetable glycerin and propylene glycol, and flavorings), a heating source/atomizer to aerosolize the fluid, and a rechargeable battery [2-4, 7]. The liquid heating process, which replaces tobacco combustion in traditional cigarette smoking, produces an aerosol containing fine particulates [2, 3, 7] that may be hazardous [3, 4, 7, 8]. These include reactive oxygen species (ROS), carbonyl compounds (formaldehyde, acetaldehyde, and acrolein), metals (copper, nickel, or silver from the wires and atomizer), and silicate particles [3, 4, 9-11]. Such toxicants have been associated with respiratory injury, cardiovascular risk, increased oxidative stress, mitochondrial dysfunction, vascular endothelial damage, inflammation, and potential carcinogens with an overlap with tobacco smoking toxicities [1, 3, 4, 12]. However, some toxicants introduced by EC use are not found in tobacco smoke [13]. Despite their widespread use among adolescents and adults, the chronic long-term effects of EC use on human health have not been well characterized [3, 4].

EC use causes oxidative stress, as documented in several in vitro and in vivo studies. In vitro, exposure of human airway epithelial cells and lung fibroblasts to EC aerosol increased inflammatory cytokine secretion [11]. In addition, when vascular endothelial cells of humans are exposed to EC aerosol extract-induced ROS, it causes DNA damage, reduced cell viability, and increased apoptosis [14]. Studies on animal models demonstrated increased oxidative stress and inflammation following exposure to EC aerosol, leading to endothelial dysfunction, and this outcome was also very similar to the effects of tobacco smoke exposure [15-18]. Several human studies also showed elevation in biomarkers of oxidative stress and impairment in endothelial function due to acute short-term EC aerosol exposure [15, 19-21].

There is a scarcity of research on the impact of EC aerosol on the brain. Prasedya and his colleagues conducted a study to evaluate the effect of short-term exposure to EC aerosol on the brain in living organisms. They also compared these effects to those caused by cigarette smoke [22]. They demonstrated that mice exposed to cigarette smoke and EC aerosol exhibited diminished cognitive spatial learning abilities and memory functions. Furthermore, the cerebral cortex histology examinations in mice brains from the group exposed to EC revealed the presence of inflammatory reactions, as indicated by elevated levels of TNF-α as a proinflammatory cytokine and the occurrence of necrosis. Research indicates that aerosol from electronic cigarettes (EC) may potentially impact mood, cognitive abilities, and memory functions in the brain, as well as potentially lead to drug dependence [23]. We have recently shown that EC aerosol exposure negatively affects memory (both short-term and long-term) in rats and leads to changes in brain chemistry, as indicated by oxidative stress biomarkers [24].

Vitamin C, also known as ascorbic acid, is a water-soluble antioxidant. It is crucial for the human body’s various physiological activities [25]. It is primarily found in the brain and is responsible for maintaining homeostasis in the central nervous system (CNS). Its antioxidant properties are crucial for preserving the balance of oxidative processes [25, 26]. VitC has a significant role in neurodevelopment and neurotransmission facilitation [27, 28]. It controls the transmission of dopaminergic, glutamatergic, GABAergic, and cholinergic neurotransmitters and the acetylcholine and catecholamines released from synaptic vesicles [28-30]. Vitamin C eliminates ROS made by glutamate, the primary excitatory brain neurotransmitter, thereby preventing and resolving glutamate-induced neurotoxicity [28]. Previous work showed that VitC deficiency can lead to cognitive impairment by impairing glutamate clearance, leading to neuronal excitotoxicity [31]. However, the potential ability of Vitamin C to preserve cognitive dysfunction and oxidative stress caused by EC exposure to aerosol was not studied. Hence, the present research aimed to investigate the hypothesis that Vitamin C’s antioxidant properties can mitigate the harms of exposure to EC aerosol in rats, specifically by preventing oxidative stress and cognitive impairment.

2. METHODS

2.1. Animals

Adult Wister male rats aged 10-12 weeks weighing 150-200 g were adapted for one week before the start of the study intervention. The animals were obtained from the Animal House of Jordan University of Science and Technology, Irbid, Jordan. Throughout the study, the animals were maintained in an environment with a constant temperature of 25 ± 1°C and a 12-hour cycle of light and darkness. They were given unrestricted access to both food and water. The animals were randomly assigned over four groups (10 rats/group): (i) Fresh air group, where the animals served as the control group. They were kept in exposure chambers with clean air and water (as the vehicle) that was given to this group by oral gavage. (ii) EC-exposed animals were exposed to EC aerosol for two hours a day with one hour of rest in between, five days a week. In addition, this group was given water via oral gavage, similar to the fresh air group. (iii) VitC-treated group in which VitC (100 mg/kg/day, Sigma, St. Louis, MO) was given by oral gavage five days a week. (iv) EC-exposed + VitC-treated group. This group was exposed to EC in group “ii” and VitC in group “iii”. The VitC treatment protocol was based on previous studies showing neuroprotective properties for conditions other than EC exposure [32-34]. All treatments were initiated on the same day and continued for four weeks.

2.2. EC Exposure Protocol

A whole-body exposure system was used. The EC-exposed group and the EC-exposed+VitC-treated group were held in the exposure chamber connected to the EC aerosol treatment system. Animals were exposed to EC aerosol as described previously [24, 35, 36]. The EC liquid was formulated using propylene glycol (PG) to vegetable glycerin (VG) (analytical grade) and free-base nicotine sourced from Sigma Aldrich (USA). The proportion of PG to VG was 7:3, and the concentration of liquid nicotine was 18 milligrams per milliliter (mg/ml). The proportions and nicotine concentration mentioned here are representative of EC liquids that are commonly found in the market [37]. The EC aerosol was discharged by a 1.8 Ω single coil EC device (Mini protank2, KangerTech, Shenzhen, China). The EC was operated at a power of 5.76 W using a reverse-puffing machine developed by the Aerosol Research Lab of the American University of Beirut [32, 33, 38], resulting in the production of aerosols. The aerosol produced is directed through the mouthpiece of the EC into the exposure chamber, which has dimensions of 38×25×25 cm (length × width × height). The exposure machine was calibrated to generate a single burst lasting four seconds and containing 116.7 mL of air every 10 seconds during the exposure period. During each hour of exposure, approximately 2 milliliters of EC liquid containing around 36 milligrams of nicotine were consumed. During the process of puffing, a pump is activated to forcefully push fresh air into the air inlet ports of EC. The animals in the control group were only exposed to fresh air.

2.3. The Radial Arm Water Maze (RAWM)

As Jibril and colleagues [39-41] described, the four groups of animals were subjected to RAWM cognitive tests to evaluate spatial learning and memory.

2.4. Hippocampus Dissection

Following the completion of cognitive testing, the rats were euthanized, and their brains were promptly dissected and placed on filter paper that had been soaked in normal saline solution and crushed ice. The hippocampi were extracted from the brain and stored in 1.5 mL tubes in a liquid nitrogen container. Ultimately, the tubes were stored at a temperature of -30°C until oxidative stress biomarkers were measured. The methodology was extensively elucidated by Alzoubi et al., 2021 [42].

2.5. Oxidative Stress Biomarkers and BDNF Measurements

To assess the oxidative stress biomarkers, the hippocampal tissue was manually homogenized using a pestle appropriate for the 1.5 mL tube. The homogenization was performed in a lysis buffer [43] and a protease inhibitor cocktail from Sigma-Aldrich Corp, MO, USA. The homogenates were centrifugated at 1400 times the force of gravity for 5 minutes at 4 degrees Celsius to separate and eliminate insoluble substances.

Total protein concentration was quantified using a commercially available BioRad kit in Hercules, CA, USA. To measure reduced glutathione (GSH) levels, the homogenates of the tissue were treated with 5-Sulfosalicylic acid. Subsequently, the mixture was centrifuged at a speed of 1000 times the force of gravity for 10 minutes at a temperature of 4°C. The resulting supernatant was then analyzed using the GSH Assay Kit, following the instructions provided by Sigma-Aldrich Corp. The GSSG analysis followed the same procedures as for reduced glutathione (GSH), except that tissue homogenates were pre-treated with 2-vinylpyridine, as specified in the kit manual. The GPx activity was measured via Sigma-Aldrich’s cellular activity assay kit (CGP1) through spectrophotometric analysis. The level of the enzyme superoxide dismutase (SOD) was determined by using the SOD assay kit, following the instructions provided by the manufacturer (Sigma-Aldrich, MO, USA). BDNF activity was quantified using a BDNF assay kit from R&D Systems, USA. The ELx800 from the Bio-tek instrument was employed to assess alterations in absorbance and quantify the specific markers.

2.6. Statistical Analysis

To evaluate the variations between different groups, two-way ANOVA was succeeded by the post-test of Bonferroni. The statistical tests utilized version 8.0 of Prism software (Graph Pad, LA Jolla, CA, USA). A P-value below 0.05 was deemed significant, and data were given as mean ± SEM.

3. RESULTS

3.1. EC Exposure and EC+VitC Treatment Effects on Spatial Learning and Cognitive Function

All rats in the four groups committed a high number of errors in the acquisition phase using RAWM. However, the number of errors decreased in the four groups without a significant difference between them as this phase continued for up to 12 consecutive trials (F(33, 555)=0.98, p > 0.05), and this was evident in the rats’ ability to locate the hidden escape platform (Fig. 1).

Fig. (1).

Fig. (1)

Animals' performance in the acquisition phase. Comparison of e-cigarette exposure (EC), vitamin C (VitC), Control, and EC+VitC. *Indicate p < 0.05.

The short-term memory test, which was conducted 30 minutes following the last learning phase trial, showed significant impairment in the EC-exposed group, with greater error numbers than the other three groups (F(1, 55)=17.47, p < 0.01; Fig. 2A). On the contrary, the error numbers committed to locating the hidden platform by the EC+VitC-treated group decreased relative to the EC-exposed group. VitC treatment alone (no EC exposure) did not influence results in the short-term memory test, with no significant difference in the error numbers between this group, the EC+VitC group, and the control group (Fig. 2A).

Fig. (2).

Fig. (2)

Animals' performance in memory tests. Comparison of e-cigarette exposure (EC), vitamin C (VitC), Control, and EC+VitC. (A) Short-term memory test at 30 minutes, (B) long-term memory test at 5 hours, and (C) long-term memory test at 24 hours. *Indicate p < 0.05.

The assessment of long-term memory was conducted at two time points: 5 hours and 24 hours following the 12th trial of the learning performance test using the RAWM. In comparison to the other three experimental animal groups, rats that were exposed to EC aerosol demonstrated a significantly greater number of errors in the 5- (F(1, 55)=15.40, p < 0.01, Fig. 2B) and 24- (F(1, 55)=15.49, p < 0.01, Fig. 2C) hour tests following the learning phase. Nevertheless, there was no significant difference in the number of errors observed between the control group and the group exposed to EC+VitC in the 5-hour (Fig. 2B) and 24-hour (Fig. 2C) long-term memory tests. There was no significant difference between the VitC-exposed group and the control group at both time points, as shown in Fig. (2).

3.2. Hippocampal levels of GSH and GSSG and their Ratio

Rats exposed to EC aerosol have significantly reduced levels of GSH (F(3, 58)=8.28, p < 0.01, Fig. 3A), elevated levels of GSSG (F(3, 58)=6.88, p < 0.05, Fig. 3B), and a reduced ratio of GSH/GSSG (F(3, 58)=11.40, p < 0.05, Fig. 3C) in comparison to the VitC-treated, EC+VitC-treated, and control groups (P < 0.05). The other three groups (i.e., control, VitC, and EC+VitC, Figs. (3A, B, and C) had no significant differences.

Fig. (3).

Fig. (3)

Levels of GSH, GSSG, and ratio of GSH/GSSG. Comparison of e-cigarette exposure (EC), vitamin C (VitC), Control, and EC+VitC. (A) Levels of GSH, (B) Levels of GSSG, and (C) Ratio of GSH/GSSG. *Indicate p < 0.05.

3.3. GPx and SOD Enzymes Activities in Hippocampal Tissue

The hippocampal antioxidant enzymatic activities of GPx (F(3, 54)=10.30, p < 0.01, Fig. 4A) and SOD (F(3, 58)=6.60, p < 0.05, Fig. 4B) in the EC-exposed were reduced significantly relative to the other three groups. In contrast, significant differences were not detected among the other three groups.

Fig. (4).

Fig. (4)

Activities of GPx and SOD. Comparison of e-cigarette exposure (EC), vitamin C (VitC), Control, and EC+VitC. (A) Activity of GPx and (B) Activity of SOD. *Indicate p < 0.05.

3.4. The Level of BDNF in Hippocampal Tissue

The hippocampal BDNF level in the EC-exposed group was significantly lower compared to the other three groups (F(3, 58)=9.97, p < 0.01, p < 0.05; Fig. 5). Significant differences were not observed among the other three groups.

Fig. (5).

Fig. (5)

Levels of BDNF. Comparison of e-cigarette exposure (EC), vitamin C (VitC), Control, and EC+VitC. *Indicate p < 0.05.

4. DISCUSSION

Limited research has specifically investigated EC aerosol exposure's effects on oxidative stress and cognitive function. Furthermore, research has not been conducted about the protective impacts of antioxidants, namely VitC, on redox balance and cognitive effects of EC aerosol exposure. Based on this, the current study identifies the impact of VitC on brain oxidative stress biomarkers and cognitive dysfunction induced by EC aerosol exposure in rats. Our findings highlight the potential neuroprotective and therapeutic role of VitC as an antioxidant that mitigates the negative consequences of exposure to EC aerosol on short-term and long-term memory, mainly by reducing oxidative stress in the brain. The present study’s results with simultaneous vitamin C along with EC may not generalize to vitamin C given after exposure. That is, the reactive oxygen species may set in motion neuroinflammation that cannot then be reversed with antioxidants.

4.1. EC Exposure and VitC Treatment effects on Cognitive Spatial Learning Ability and Cognitive Memory Function

The brain is highly susceptible to oxidative stress due to the post-mitotic nature of neurons and their high levels of oxygen requirements [44]. Neurodegenerative diseases have been associated with increased compromised antioxidant defenses, resulting in increased ROS levels. These factors result in cognitive decline, oxidative stress in neurons, long-term inflammation, calcium dysregulation, dysfunction of mitochondria, cell damage, hyperactivity of glutamate, and apoptotic effects [25, 28].

Generated ROS can be neutralized by enzymatic (GPx, SOD, catalase, and glutathione reductase) and non-enzymatic antioxidants (VitC, VitE, glutathione, and α-lipoic acid) [28, 45, 46]. VitC scavenges free radicals, reduces oxidative stress, inhibits acetylcholinesterase, which possesses a crucial function in learning and memory, and may help limit the decline of cognitive functions [25, 47, 48]. Therefore, Vitamin C is crucial for restoring or preserving redox homeostasis in oxidative conditions [49]. Vitamin C concentration is elevated in the CNS compared to plasma levels, with the cerebral cortex, hippocampus, and amygdala exhibiting the highest concentrations [27, 50, 51].

This study found that exposure to EC aerosol impaired rats’ cognitive spatial memory in the short- and long-term. At the same time, VitC administration to animals exposed to EC aerosol prevented this negative impact of EC exposure on memory impairments. Previous studies have shown that EC exposure for 1 or 4 weeks has not affected the learning phase of rats [24], and chronic nicotine treatment for 4-6 weeks has normalized impaired learning induced during hypothyroidism in rats [52]. This could be due to nicotine's documented positive effects on the brain's cognitive function [53]. EC exposure for 12 weeks has impaired rats' learning ability [24], which could be explained by nicotinic acetylcholine receptors desensitized to long-term nicotine exposure from EC [54, 55]. In another study [22], a rat’s learning process was negatively impacted by exposure to either ECs or conventional cigarettes for 14 days, which could be explained by the differences in the performed procedures and protocols of the various studies, particularly in terms of the used puffing topography and the time frame of the learning phase (i.e., during the 12 trials of training [24] versus the next day after training [22]). Our observed VitC effect in protecting animals from ECs-induced memory impairment is consistent with previous findings in PTSD-like behavioral models in rats where VitC administration successfully reduced memory impairment [32]. In addition, we have previously demonstrated that waterpipe smoke exposure causes both short-term and long-term impairment of rats' memory. However, we have also found that administering Vitamin C can prevent this detrimental effect [33]. Multiple other studies have demonstrated markedly reduced blood concentrations of Vitamin C in humans with cognitive decline in comparison to those in good health [27, 56-58]. Furthermore, two cross-sectional studies have shown that a deficiency in Vitamin C may result in neurocognitive dysfunction and is associated with more severe cognitive impairment [59, 60].

4.2. Levels and Enzymatic Activities of Hippocampal Oxidative Stress Biomarkers

Consistent with our observations in rats, the inhalation of EC aerosol by mice resulted in an elevation of cytokines that are pro-inflammatory and a decrease in the levels of glutathione in the lungs. These changes are important for keeping the redox stability of the cell [11]. In addition, VitC administration attenuated all changes observed in oxidative stress markers in the PTSD rat model [32]. Moreover, this also agreed with VitC, preventing reduced hippocampal ratio of GSH: GSSG and GPx activity reduced by waterpipe tobacco smoking [33]. Vitamin C’s impact on biomarkers of oxidative stress and cognitive function may be attributed, in part, to the synergistic effects of antioxidants. Other antioxidant regeneration, including glutathione, vitamin E, and catalase, is promoted by Vitamin C [61-63].

4.3. The BDNF levels in Hippocampal Tissues

The BDNF is extensively present in the mature mammal brain, with its most abundant concentrations found in the hippocampus [64]. Neurons and synaptic plasticity are regulated by a crucial process involving BDNF that controls their survival, differentiation, growth, and apoptosis [65]. Additionally, it has functions in the cognitive processes of learning and memory in adults [66, 67]. In healthy adults, circulating BDNF may serve as a marker for memory and overall well-being of cognition [68]. Both laboratory studies conducted on cells and animal studies have established a connection between Vitamin C and the stimulation of the expression and production of BDNF [69-72].

CONCLUSION AND STUDY LIMITATIONS

The current study has some limitations. For example, the animals used in the current study are adults with an age of around 10-12 weeks. Older animals could have higher levels of free iron or copper ions that could elicit the pro-oxidant effects of vitamin C. Also, the dose of Vitamin C used in the current study was to prove the pharmacological concept. It was based on previous studies that showed the protective effect of Vitamin C in multiple conditions other than EC exposure [32-34]. Future studies should construct tests for lower Vitamin C doses, which should be based on the present concept study.

In conclusion, the present results showed that chronic vitamin C administration prevented BDNF reduction induced by EC exposure, which aligns with the available evidence. Therefore, vitamin C’s protective effects on neuronal oxidative stress may be due to its impact on enhancing the expression of BDNF.

ACKNOWLEDGEMENTS

We acknowledge Jordan University of Science and Technology for supplying Prof. Karem H. Alzoubi with sabbatical leave.

LIST OF ABBREVIATIONS

CNS

Central Nervous System

ECs

Electronic Cigarettes

PG

Propylene Glycol

ROS

Reactive Oxygen Species

SOD

Superoxide Dismutase

VG

Vegetable Glycerin

AUTHORS’ CONTRIBUTIONS

The authors confirm their contribution to the paper as follows: K.H.Z., O.F.K, N.A., E.M.A, A.J., R.H., N.A., M.A.A., T.K.A., and T.E. were involved in the study design and conception. K.H.Z., O.F.K, N.A., N.A., M.A.A., and T.K.A. were involved in study implantation and data analysis, K.H.Z., O.F.K, N.A., E.M.A, A.J., R.H., N.A., M.A.A., T.K.A., and T.E. interpreted the study results. K.H.Z., O.F.K, E.M.A, A.J., R.H., and N.A. wrote the manuscript. All authors revised the manuscript's final draft.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

The protocol of this study was approved by the Animal Care and Use Committee of Jordan University of Science and Technology (Approval # 425-2020).

HUMAN AND ANIMAL RIGHTS

All the animals were treated according to the guidelines of the Animal Care and Use Committee of Jordan University of Science and Technology.

This study adheres to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIALS

Data will be available upon reasonable request via e-mailing the corresponding author.

FUNDING

This project was funded by Jordan University of Science and Technology (Deanship of Research, grant no. 400/2020).

CONFLICT OF INTEREST

Dr. Eissenberg has been a paid consultant in litigation against the tobacco industry and also the electronic cigarette industry and is named on one patent for a device that measures the puffing behavior of electronic cigarette users and on a patent application for a smartphone app that determines electronic cigarette device and liquid characteristics. The other authors declare no conflict of interest, financial or otherwise.

REFERENCES

  • 1.Feeney S., Rossetti V., Terrien J. E-Cigarettes-a review of the evidence-harm versus harm reduction. Tob Use Insights. 2022;15:1179173X221087524. doi: 10.1177/1179173X221087524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Münzel T., Hahad O., Kuntic M., Keaney J.F., Jr, Deanfield J.E., Daiber A. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur. Heart J. 2020;41(41):4057–4070. doi: 10.1093/eurheartj/ehaa460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Marques P., Piqueras L., Sanz M.J. An updated overview of e-cigarette impact on human health. Respir. Res. 2021;22(1):151. doi: 10.1186/s12931-021-01737-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bhatt J.M., Ramphul M., Bush A. An update on controversies in e-cigarettes. Paediatr. Respir. Rev. 2020;36:75–86. doi: 10.1016/j.prrv.2020.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jerzyński T., Stimson G.V., Shapiro H., Król G. Estimation of the global number of e-cigarette users in 2020. Harm Reduct. J. 2021;18(1):109. doi: 10.1186/s12954-021-00556-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Eissenberg T., Bhatnagar A., Chapman S., Jordt S.E., Shihadeh A., Soule E.K. Invalidity of an oft-cited estimate of the relative harms of electronic cigarettes. Am. J. Public Health. 2020;110(2):161–162. doi: 10.2105/AJPH.2019.305424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.E-Cigarettes. Vapes, and other Electronic Nicotine Delivery Systems (ENDS). 2024. Available from: https://www.fda.gov/tobacco-products/products-ingredients-components/e-cigarettes-vapes-and-other-electronic-nicotine-delivery-systems-ends.
  • 8.Benowitz N.L., St Helen G., Liakoni E. Clinical pharmacology of electronic nicotine delivery systems (ENDS): Implications for benefits and risks in the promotion of the combusted tobacco endgame. J. Clin. Pharmacol. 2021;61(Suppl. 2):S18–S36. doi: 10.1002/jcph.1915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tierney P.A., Karpinski C.D., Brown J.E., Luo W., Pankow J.F. Flavour chemicals in electronic cigarette fluids. Tob. Control. 2016;25(e1):e10–e15. doi: 10.1136/tobaccocontrol-2014-052175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Goel R., Durand E., Trushin N., Prokopczyk B., Foulds J., Elias R.J., Richie J.P., Jr Highly reactive free radicals in electronic cigarette aerosols. Chem. Res. Toxicol. 2015;28(9):1675–1677. doi: 10.1021/acs.chemrestox.5b00220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lerner C.A., Sundar I.K., Yao H., Gerloff J., Ossip D.J., McIntosh S., Robinson R., Rahman I. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015;10(2):e0116732. doi: 10.1371/journal.pone.0116732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Moghe A., Ghare S., Lamoreau B., Mohammad M., Barve S., McClain C., Joshi-Barve S. Molecular mechanisms of acrolein toxicity: Relevance to human disease. Toxicol. Sci. 2015;143(2):242–255. doi: 10.1093/toxsci/kfu233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Vassey J., Metayer C., Kennedy C.J., Whitehead T.P. Vape: Measuring E-cigarette influence on instagram with deep learning and text analysis. Front. Commun. (Lausanne) 2020;4:75. doi: 10.3389/fcomm.2019.00075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Anderson C., Majeste A., Hanus J., Wang S. E-cigarette aerosol exposure induces reactive oxygen species, DNA damage, and cell death in vascular endothelial cells. Toxicol. Sci. 2016;154(2):332–340. doi: 10.1093/toxsci/kfw166. [DOI] [PubMed] [Google Scholar]
  • 15.Kuntic M., Oelze M., Steven S., Kröller-Schön S., Stamm P., Kalinovic S., Frenis K., Vujacic-Mirski K., Bayo J.M.T., Kvandova M., Filippou K., Al Zuabi A., Brückl V., Hahad O., Daub S., Varveri F., Gori T., Huesmann R., Hoffmann T., Schmidt F.P., Keaney J.F., Jr, Daiber A., Münzel T. Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: Evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2). Eur. Heart J. 2020;41(26):2472–2483. doi: 10.1093/eurheartj/ehz772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Olfert I.M., DeVallance E., Hoskinson H., Branyan K.W., Clayton S., Pitzer C.R., Sullivan D.P., Breit M.J., Wu Z., Klinkhachorn P., Mandler W.K., Erdreich B.H., Ducatman B.S., Bryner R.W., Dasgupta P., Chantler P.D. Chronic exposure to electronic cigarettes results in impaired cardiovascular function in mice. J. Appl. Physiol. 2018;124(3):573–582. doi: 10.1152/japplphysiol.00713.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rao P., Liu J., Springer M.L. JUUL and combusted cigarettes comparably impair endothelial function. Tob. Regul. Sci. 2020;6(1):30–37. doi: 10.18001/TRS.6.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nabavizadeh P., Liu J., Havel C.M., Ibrahim S., Derakhshandeh R., Jacob P., III, Springer M.L. Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob. Control. 2018;27(Suppl. 1):s13–s19. doi: 10.1136/tobaccocontrol-2018-054325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Vlachopoulos C., Ioakeimidis N., Abdelrasoul M., Terentes-Printzios D., Georgakopoulos C., Pietri P., Stefanadis C., Tousoulis D. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J. Am. Coll. Cardiol. 2016;67(23):2802–2803. doi: 10.1016/j.jacc.2016.03.569. [DOI] [PubMed] [Google Scholar]
  • 20.Carnevale R., Sciarretta S., Violi F., Nocella C., Loffredo L., Perri L., Peruzzi M., Marullo A.G.M., De Falco E., Chimenti I., Valenti V., Biondi-Zoccai G., Frati G. Acute impact of tobacco vs. electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150(3):606–612. doi: 10.1016/j.chest.2016.04.012. [DOI] [PubMed] [Google Scholar]
  • 21.Chaumont M., de Becker B., Zaher W., Culié A., Deprez G., Mélot C., Reyé F., Van Antwerpen P., Delporte C., Debbas N., Boudjeltia K.Z., van de Borne P. Differential effects of E-cigarette on microvascular endothelial function, arterial stiffness and oxidative stress: A randomized crossover trial. Sci. Rep. 2018;8(1):10378. doi: 10.1038/s41598-018-28723-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Prasedya E.S., Ambana Y., Martyasari N.W.R., Aprizal Y. Nurrijawati, Sunarpi, Short-term E-cigarette toxicity effects on brain cognitive memory functions and inflammatory responses in mice. Toxicol. Res. 2020;36(3):267–273. doi: 10.1007/s43188-019-00031-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ponzoni L., Moretti M., Sala M., Fasoli F., Mucchietto V., Lucini V., Cannazza G., Gallesi G., Castellana C.N., Clementi F., Zoli M., Gotti C., Braida D. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur. Neuropsychopharmacol. 2015;25(10):1775–1786. doi: 10.1016/j.euroneuro.2015.06.010. [DOI] [PubMed] [Google Scholar]
  • 24.Alzoubi K.H., Batran R.M., Al-Sawalha N.A., Khabour O.F., Karaoghlanian N., Shihadeh A., Eissenberg T. The effect of electronic cigarettes exposure on learning and memory functions: Behavioral and molecular analysis. Inhal. Toxicol. 2021;33(6-8):234–243. doi: 10.1080/08958378.2021.1954732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Moretti M., Fraga D.B., Rodrigues A.L.S. Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases. CNS Neurosci. Ther. 2017;23(12):921–929. doi: 10.1111/cns.12767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kaźmierczak-Barańska J., Boguszewska K., Adamus-Grabicka A., Karwowski B.T. Two faces of vitamin C—Antioxidative and Pro-oxidative agent. Nutrients. 2020;12(5):1501. doi: 10.3390/nu12051501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Travica N., Ried K., Sali A., Scholey A., Hudson I., Pipingas A. Vitamin C status and cognitive function: A systematic review. Nutrients. 2017;9(9):960. doi: 10.3390/nu9090960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hamid M., Mansoor S., Amber S., Zahid S. A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease. Front. Aging Neurosci. 2022;14:970263. doi: 10.3389/fnagi.2022.970263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Plevin D., Galletly C. The neuropsychiatric effects of vitamin C deficiency: A systematic review. BMC Psychiatry. 2020;20(1):315. doi: 10.1186/s12888-020-02730-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Harrison F.E., May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009;46(6):719–730. doi: 10.1016/j.freeradbiomed.2008.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mi D.J., Dixit S., Warner T.A., Kennard J.A., Scharf D.A., Kessler E.S., Moore L.M., Consoli D.C., Bown C.W., Eugene A.J., Kang J.Q., Harrison F.E. Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice. Neurobiol. Aging. 2018;71:241–254. doi: 10.1016/j.neurobiolaging.2018.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Alzoubi K.H., Shatnawi A.F., Al-Qudah M.A., Alfaqih M.A. Vitamin C attenuates memory loss induced by post-traumatic stress like behavior in a rat model. Behav. Brain Res. 2020;379:112350. doi: 10.1016/j.bbr.2019.112350. [DOI] [PubMed] [Google Scholar]
  • 33.Alqudah M.A.Y., Alzoubi K.H., Ma’abrih G.M., Khabour O.F. Vitamin C prevents memory impairment induced by waterpipe smoke: Role of oxidative stress. Inhal. Toxicol. 2018;30(4-5):141–148. doi: 10.1080/08958378.2018.1474977. [DOI] [PubMed] [Google Scholar]
  • 34.Mhaidat N.M., Alzoubi K.H., Khabour O.F., Tashtoush N.H., Banihani S.A., Abdul-razzak K.K. Exploring the effect of vitamin C on sleep deprivation induced memory impairment. Brain Res. Bull. 2015;113:41–47. doi: 10.1016/j.brainresbull.2015.02.002. [DOI] [PubMed] [Google Scholar]
  • 35.Mayyas F., Aldawod H., Alzoubi K.H., Khabour O., Shihadeh A., Eissenberg T. Comparison of the cardiac effects of electronic cigarette aerosol exposure with waterpipe and combustible cigarette smoke exposure in rats. Life Sci. 2020;251:117644. doi: 10.1016/j.lfs.2020.117644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Taha H.R., Al-Sawalha N.A., Alzoubi K.H., Khabour O.F. Effect of E-Cigarette aerosol exposure on airway inflammation in a murine model of asthma. Inhal. Toxicol. 2020;32(13-14):503–511. doi: 10.1080/08958378.2020.1856238. [DOI] [PubMed] [Google Scholar]
  • 37.El-Hellani A., Salman R., El-Hage R., Talih S., Malek N., Baalbaki R., Karaoghlanian N., Nakkash R., Shihadeh A., Saliba N.A. Nicotine and carbonyl emissions from popular electronic cigarette products: Correlation to liquid composition and design characteristics. Nicotine Tob. Res. 2018;20(2):215–223. doi: 10.1093/ntr/ntw280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Al-Sawalha N.A., Bdeir R., Sohaib A., Saad M., Inghaimesh T., Khabour O.F., Alzoubi K.H., Shihadeh A. Effect of E-cigarettes aerosol exposure during lactation in rats: Hormonal and biochemical aspects. Environ. Toxicol. Pharmacol. 2021;88:103759. doi: 10.1016/j.etap.2021.103759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jibril T.I., Alzoubi K.H., Mhaidat N.M., Khabour O.F., Alqudah M.A.Y., Rababa’h A.M., Alrabadi N., Al-Udatt D. Sildenafil prevents chronic psychosocial stress-induced working memory impairment: Role of brain-derived neurotrophic factor. Curr. Res. Pharmacol. Drug Discov. 2024;6:100182. doi: 10.1016/j.crphar.2024.100182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Alzoubi K.H., Khabour O.F., Alfaqih M., Tashtoush M., Al-Azzam S.I., Mhaidat N.M., Alrabadi N. The protective effects of pioglitazone against cognitive impairment caused by L-methionine administration in a rat model. CNS Neurol. Disord. Drug Targets. 2022;21(1):77–84. doi: 10.2174/1871527320666210809122523. [DOI] [PubMed] [Google Scholar]
  • 41.Alzoubi K.H., Aburashed Z.O., Mayyas F. Edaravone protects from memory impairment induced by chronic L-methionine administration. Naunyn Schmiedebergs Arch. Pharmacol. 2020;393(7):1221–1228. doi: 10.1007/s00210-020-01827-z. [DOI] [PubMed] [Google Scholar]
  • 42.Alzoubi K.H., Khabour O.F., Al-Awad R.M., Aburashed Z.O. Every-other day fasting prevents memory impairment induced by high fat-diet: Role of oxidative stress. Physiol. Behav. 2021;229:113263. doi: 10.1016/j.physbeh.2020.113263. [DOI] [PubMed] [Google Scholar]
  • 43.Massadeh A.M., Alzoubi K.H., Milhem A.M., Rababa’h A.M., Khabour O.F. Evaluating the effect of selenium on spatial memory impairment induced by sleep deprivation. Physiol. Behav. 2022;244:113669. doi: 10.1016/j.physbeh.2021.113669. [DOI] [PubMed] [Google Scholar]
  • 44.Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Beal M.F. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 2002;59(5):794–798. doi: 10.1001/archneur.59.5.794. [DOI] [PubMed] [Google Scholar]
  • 45.Pham-Huy L.A., He H., Pham-Huy C. Free radicals and antioxidants in human health. J. Assoc. Physicians India. 2008;52(794804):794–804. [PubMed] [Google Scholar]
  • 46.Devasagayam T.P., Tilak J.C., Boloor K.K., Sane K.S., Ghaskadbi S.S., Lele R.D. Free radicals, antioxidants and functional foods: Impact on human health. J. Assoc. Physicians India. 2004;4(8):118–126. [PubMed] [Google Scholar]
  • 47.Olajide O.J., Yawson E.O., Gbadamosi I.T., Arogundade T.T., Lambe E., Obasi K., Lawal I.T., Ibrahim A., Ogunrinola K.Y. Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer’s disease. Environ. Toxicol. Pharmacol. 2017;50:200–211. doi: 10.1016/j.etap.2017.02.010. [DOI] [PubMed] [Google Scholar]
  • 48.Ambali S.F., Idris S.B., Onukak C., Shittu M., Ayo J.O. Ameliorative effects of vitamin C on short-term sensorimotor and cognitive changes induced by acute chlorpyrifos exposure in Wistar rats. Toxicol. Ind. Health. 2010;26(9):547–558. doi: 10.1177/0748233710373086. [DOI] [PubMed] [Google Scholar]
  • 49.May J., Huang J., Qu Z. Macrophage uptake and recycling of ascorbic acid: Response to activation by lipopolysaccharide. Free Radic. Biol. Med. 2005;39(11):1449–1459. doi: 10.1016/j.freeradbiomed.2005.07.006. [DOI] [PubMed] [Google Scholar]
  • 50.Mefford I.N., Oke A.F., Adams R.N. Regional distribution of ascorbate in human brain. Brain Res. 1981;212(1):223–226. doi: 10.1016/0006-8993(81)90056-1. [DOI] [PubMed] [Google Scholar]
  • 51.Oke A.F., May L., Adams R.N. Ascorbic acid distribution patterns in human brain. Ann. N. Y. Acad. Sci. 1987;498(1):1–12. doi: 10.1111/j.1749-6632.1987.tb23747.x. [DOI] [PubMed] [Google Scholar]
  • 52.Alzoubi K.H., Aleisa A.M., Gerges N.Z., Alkadhi K.A. Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J. Neurosci. Res. 2006;84(5):944–953. doi: 10.1002/jnr.21014. [DOI] [PubMed] [Google Scholar]
  • 53.Valentine G., Sofuoglu M. Cognitive effects of nicotine: Recent progress. Curr. Neuropharmacol. 2018;16(4):403–414. doi: 10.2174/1570159X15666171103152136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Picciotto M., Addy N., Mineur Y., Brunzell D. It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog. Neurobiol. 2008;84(4):329–342. doi: 10.1016/j.pneurobio.2007.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Quick M.W., Lester R.A.J. Desensitization of neuronal nicotinic receptors. J. Neurobiol. 2002;53(4):457–478. doi: 10.1002/neu.10109. [DOI] [PubMed] [Google Scholar]
  • 56.Rinaldi P., Polidori M.C., Metastasio A., Mariani E., Mattioli P., Cherubini A., Catani M., Cecchetti R., Senin U., Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol. Aging. 2003;24(7):915–919. doi: 10.1016/S0197-4580(03)00031-9. [DOI] [PubMed] [Google Scholar]
  • 57.Rivière S., Birlouez-Aragon I., Nourhashémi F., Vellas B. Low plasma vitamin C in alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry. 1998;13(11):749–754. doi: 10.1002/(SICI)1099-1166(1998110)13:11<749::AID-GPS860>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  • 58.Polidori M.C., Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J. Alzheimers Dis. 2002;4(6):517–522. doi: 10.3233/JAD-2002-4608. [DOI] [PubMed] [Google Scholar]
  • 59.Pearson J., Pullar J., Wilson R., Spittlehouse J., Vissers M., Skidmore P., Willis J., Cameron V., Carr A., Vitamin C. Vitamin C status correlates with markers of metabolic and cognitive health in 50-year-olds: Findings of the chalice cohort study. Nutrients. 2017;9(8):831. doi: 10.3390/nu9080831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gale C.R., Martyn C.N., Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312(7031):608–611. doi: 10.1136/bmj.312.7031.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Jackson T.S., Xu A., Vita J.A., Keaney J.F., Jr Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 1998;83(9):916–922. doi: 10.1161/01.RES.83.9.916. [DOI] [PubMed] [Google Scholar]
  • 62.Harrison F.E. A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer’s disease. J. Alzheimers Dis. 2012;29(4):711–726. doi: 10.3233/JAD-2012-111853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 1999;72(6):2523–2530. doi: 10.1046/j.1471-4159.1999.0722523.x. [DOI] [PubMed] [Google Scholar]
  • 64.Hofer M., Pagliusi S.R., Hohn A., Leibrock J., Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 1990;9(8):2459–2464. doi: 10.1002/j.1460-2075.1990.tb07423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hong C.J., Liou Y.J., Tsai S.J. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 2011;86(5-6):287–297. doi: 10.1016/j.brainresbull.2011.08.019. [DOI] [PubMed] [Google Scholar]
  • 66.Poo M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001;2(1):24–32. doi: 10.1038/35049004. [DOI] [PubMed] [Google Scholar]
  • 67.Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269. doi: 10.1016/S0092-8674(03)00035-7. [DOI] [PubMed] [Google Scholar]
  • 68.Komulainen P., Pedersen M., Hänninen T., Bruunsgaard H., Lakka T.A., Kivipelto M., Hassinen M., Rauramaa T.H., Pedersen B.K., Rauramaa R. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA study. Neurobiol. Learn. Mem. 2008;90(4):596–603. doi: 10.1016/j.nlm.2008.07.014. [DOI] [PubMed] [Google Scholar]
  • 69.Travica N., Ried K., Sali A., Hudson I., Scholey A., Pipingas A. Plasma vitamin C concentrations and cognitive function: A cross-sectional study. Front. Aging Neurosci. 2019;11:72. doi: 10.3389/fnagi.2019.00072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Delrobaei F., Fatemi I., Shamsizadeh A., Allahtavakoli M. Ascorbic acid attenuates cognitive impairment and brain oxidative stress in ovariectomized mice. Pharmacol. Rep. 2019;71(1):133–138. doi: 10.1016/j.pharep.2018.10.001. [DOI] [PubMed] [Google Scholar]
  • 71.Spector R. Dehydroascorbic acid for the treatment of acute ischemic stroke. Med. Hypotheses. 2016;89:32–36. doi: 10.1016/j.mehy.2016.01.021. [DOI] [PubMed] [Google Scholar]
  • 72.Grant M.M., Barber V.S., Griffiths H.R. The presence of ascorbate induces expression of brain derived neurotrophic factor in SH-SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival. Proteomics. 2005;5(2):534–540. doi: 10.1002/pmic.200300924. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be available upon reasonable request via e-mailing the corresponding author.


Articles from Current Neuropharmacology are provided here courtesy of Bentham Science Publishers

RESOURCES